medline.ch Onkologie Blut

	Second-line bosutinib for chronic phase chronic myeloid leukemia after imatinib: final, 10-year results of a phase I/II study. Haematologica Gambacorti-Passerini C, Brümmendorf TH, Kim DW, Goh YT, Dyagil I, Pagnano K, Batai A, Turkina AG, Leip E, Purcell S, Leone J, Viqueira A, Cortes JE. PMID: 42312395 [PubMed - as supplied by publisher]
	Beyond the Surface: Duodenal-Type Follicular Lymphoma Diagnosed Despite Normal-Appearing Duodenal Mucosa and Absence of Focal Duodenal FDG Uptake. Case Rep Gastrointest Med Vinton Z, Schulz C, McGuire W, Hafeez S, Malik S. PMID: 42312190 [PubMed]
	Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy. Clinicoecon Outcomes Res Ghetti G, Castello L, Odonde LA, De Fazio S, Stella A, Bruno A, Marchionne E, Bonifacio M. PMID: 42311575 [PubMed]
	Real-world resource utilization, toxicity management, and efficacy outcomes of CD20â€‰Ã—â€‰CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network. Hemasphere Bastos-Oreiro M, Iacoboni G, Navarro V, Martínez C, Manresa P, Magnano L, Jiménez-Ubieto A, Vázquez S, Rodriguez MJ, Busnego MT, Del Campo R, Paúl PJ, Murillo I, Donato EM, Serna A, Luzardo H, Gómez P, Pérez E, Mendibil B, Ramos S, García-Noblejas A, Gonzalez de Villambrosia S, Díaz FJ, López J, Martín-Moro F, Fernandez-Caldas P, Fernandez R, Gutierrez A, Sánchez B, Domínguez N, Civeira M, Villafuerte P, Olazabal I, Zeberio I, Barrenetxea C, Gutierrez N, Romero S, Martín-Consuegra S, Huerga S, Golbano N, Riaza R, Hueso JA, Martinez-Barranco P, Navarro B, Villalón L, Ortega P, Torres A, Ormenazabal I, Sanchez Anton MP, Goñi MA, Abrisqueta P, Martín García-Sancho A. PMID: 42311429 [PubMed]
	Disseminated Tuberculosis Mimicking Metastatic Cancer During Ruxolitinib Therapy for Polycythemia Vera: A Case Report and Literature Review. Am J Case Rep Ono Y, Oka K, Ishikawa K, Shikata H, Kaneko M. PMID: 42310931 [PubMed - indexed for MEDLINE]
	BTKi orelabrutinib improved the outcome of newly-diagnosed PCNS-LBCL by alleviating MyD88(L265P)-induced PIM1 stability. J Hematol Oncol Yuan Y, Dai B, Zhong H, Zheng J, Fan Z, Chen D, Wang Q, Wu H, Li Y, Zhu P, Ding T, Wang S, Wu K, Zhang Y, Wang Z, Feng R, Zhu F, Zheng K, Qin Z, Yang B, Chen H, Lin X, Yao Y, Zhuang D, Shi Z, Mao Y, Chen T. PMID: 42310786 [PubMed - indexed for MEDLINE]
	Cumulative incidence and prognostic factors for leukemic transformation in chronic myelomonocytic leukemia: a competing risk analysis. BMC Cancer Huang J, Zheng C, Liu Y, Li C, Xin X. PMID: 42310629 [PubMed - as supplied by publisher]
	BLAST demonstrates higher prognostic accuracy for survival than CPSS in Chinese patients with chronic myelomonocytic leukemia. Blood Cancer J Yan X, Feng G, Cai Z, Ma J, Xu S, Ge Z. PMID: 42310291 [PubMed - in process]
	TIM-3 as an immune and leukemia stem-cell biomarker in acute myeloid leukemia: diagnostic laboratory and translational perspectives. Clin Chim Acta Bhat AA, Fuloria S, Thapa R, Narain K, Bhatia S, Ansari MT, Agnihotri S, Wu YS, Meenakshi DU, Fuloria NK. PMID: 42309212 [PubMed - as supplied by publisher]
	Mutation-specific NPM1 immunohistochemistry is a sensitive method for detecting residual disease in mid- and postinduction bone marrows: comparison of NPM1 immunohistochemistry, NPM1 real-time polymerase chain reaction, and flow cytometric studies. Am J Clin Pathol Hong E, Bailey NG, Davis KE, Matsumoto NP, Moore EM, Rea B, Aggarwal N, Monaghan SA, Jawad M. PMID: 42309046 [PubMed - indexed for MEDLINE]
	Patient-reported outcomes in BRUIN CLL-321: A randomized phase 3 trial comparing pirtobrutinib to investigators choice of idelalisib plus rituximab or bendamustine plus rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma in the post-cBTKi setting. J Geriatr Oncol Ghia P, Rossi D, Ferrant E, de la Cruz Vicente F, Maruyama D, Banerji V, Cobb P, Namburi S, Greil R, Sharman JP, Hess LM, Payakachat N, Bhandari NR, Ruppert AS, Wang D, Abada P, Loubert A, Creel K, Qiao C, Han Y, Hill M, Leow CC, Coombs CC, Barr PM. PMID: 42308688 [PubMed - as supplied by publisher]
	Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma. Blood Adv Xu-Monette ZY, Wang C, Wu D, Tzankov A, Møller MB, Visco C, Hsi ED, Zhao X, Lv B, Wang B, Cao X, Yao S, Chiu A, Dybkaer K, Bhagat G, Zu Y, Montes-Moreno S, Pan Z, Bernal-Mizrachi L, van Krieken JHJ, Choi WWL, Tam W, Chen W, Ponzoni M, Ferreri AJM, Parsons BMM, Khajouei F, Sikkink K, Li Y, Hastie AR, Schmitt AD, Young KH. PMID: 42308239 [PubMed - as supplied by publisher]
	Conjugated Hyperbilirubinemia in Pediatric Acute Lymphoblastic Leukemia at Diagnosis: A Case Series. Indian Pediatr Verma S, Mishra AK, Subramanian K, Pandey S. PMID: 42307897 [PubMed - as supplied by publisher]
	Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies. Curr Oncol Rep LaGalbo S, Foley MT, Metropulos AE, Burton KA, Principe DR. PMID: 42307813 [PubMed - indexed for MEDLINE]
	Longitudinal changes in nutritional status during induction chemotherapy and their association with treatment outcomes in pediatric patients with newly diagnosed acute myeloid leukemia. Front Med (Lausanne) Liu CL, Yan FL, Li XL. PMID: 42305964 [PubMed]
	From monoclonals to bispecific T cell engagers: the evolving antibody-based therapy landscape in acute myeloid leukemia. Front Immunol Rasouli M, Dalem M, Raaijmakers MHGP, Katsikis PD, Erkeland SJ. PMID: 42305542 [PubMed - indexed for MEDLINE]
	Beyond traditional survival estimates: conditional survival and individualized prognosis in primary breast lymphoma. Transl Cancer Res Zhang H, Wu G, Liao C. PMID: 42305490 [PubMed]
	Mogamulizumab for adult T-cell leukemia/lymphoma: a literature review. Transl Cancer Res Jones C, Wang JC, Saeed H. PMID: 42305457 [PubMed]
	Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis. Transl Cancer Res Huang L, Chen K, Wang M, Guo C, Li Y, Yu Q, Liu Z, Li Z. PMID: 42305450 [PubMed]
	Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) inÂ 1st Line Mantle Cell Lymphoma. Am J Hematol Smith SD, Sundaram S, Giri S, Ness A, Wang Y, Gopal AK, Pang Y, Tatoian ET, Grossfeld T, Lynch RC, Warren EH, Nowakowski GS, Park SI. PMID: 42305039 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 168362

Seite 1 von 8419

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung